Avalyn Pharma Inc. (AVLN) income statement
AVLNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$28.40−0.30 (-1.05%)
Close on Nov 20, 2026Market cap $1.26BP/E –Yield –
Avalyn Pharma Inc. financial ratios
See a number that looks wrong?